KALA BIO must meet $1 bid test by Nov. 30 for listing
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
KALA BIO, Inc. received a Nasdaq Hearings Panel decision allowing continued listing on The Nasdaq Capital Market, subject to conditions. The decision followed a staff determination that KALA’s closing bid price was below $1.00 per share for 30 consecutive business days, from July 16 through August 26, 2026. KALA must evidence a closing bid price of at least $1.00 per share for ten consecutive business days by November 30, 2026, then maintain a closing bid price of at least $1.00 for each trading day after November 30 until February 23, 2027.
If KALA maintains compliance until February 23, 2027, the Panel intends to impose a discretionary monitor for the next year. The Panel reserved the right to reconsider its decision if, in its opinion, an event, condition or circumstance makes continued listing inadvisable or unwarranted. KALA said there can be no assurance it will meet the conditions or maintain compliance with continued-listing requirements.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- None.
Negative
- Major point. Forward-looking: it has not happened yet and may not happen.Nasdaq listing remains conditional on meeting the $1.00 bid-price tests.
Filing Explained
The decision also covers a breach of another Nasdaq listing rule before
8-K Event Classification
Key Figures
Key Terms
minimum bid price requirement regulatory
Nasdaq Listing Rule 5550(a)(2) regulatory
discretionary monitor regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does KALA need to do to keep its Nasdaq listing?
Will KALA be monitored after meeting Nasdaq’s conditions?
AI-generated analysis. How Rhea-AI works. Not financial advice.